期刊文献+

强的松龙·葡聚糖连接物在大鼠胃肠道内容物中的水解 被引量:8

Prednisolone-dextran conjugate hydrolysis in rat gastrointestinal tract contents
下载PDF
导出
摘要 目的 观察强的松龙·葡聚糖 (平均 Mr5 0万 )连接物的结肠定向释放特性 .方法 通过将所合成的强的松龙·葡聚糖连接物与大鼠胃肠道不同部位内容物稀释液一起孵育 ,观察强的松龙的释放情况 .结果 在 1 6 0 min的孵育过程中 ,强的松龙·葡聚糖连接物在胃肠道上部内容物中水解释放出少量强的松龙及强的松龙琥珀酸半酯 ,最大释放量小于3μm ol·L- 1 ;而在胃肠道下部内容物中水解释放出大量强的松龙及强的松龙琥珀酸半酯 ,最大释放量为 1 4μmol· L- 1 .结论 葡聚糖可保护其与强的松龙相连接的酯键免受胃肠道上部酯酶的水解 ,使强的松龙集中在结肠释放 .强的松龙·葡聚糖连接物可为一种能在结肠定向转释的药物 . AIM To observe whether prednisolone·dextran (average K relative molecular mass 50×10 4) conjugate has potential in colon specific delivery of prednisolone. METHODS Prednisolone·dextran conjugate was incubated in rat contents of different part of gastrointestinal (GI) tract at 37℃, and the release of prednisolone was detected. RESULTS In 160 minutes incubation with 10 fold dilution of gastrointestinal tract contents, the concentration of drug released as prednisolone and prednisolonehemisuccinate in up per gastrointestinal tract was less than 3 μmol·L -1 ; whereas the concentration of drug released as prednisolone and prednisolonehemisuccinate in large intestine was 14 μmol·L -1 . CONCLUSION Dextran backbone protects drug polymer ester bound from hydrolysis by small intestinal esterases, and prednisolone·dextran conjugate has potential in colon specific delivery of prednisolone.
出处 《第四军医大学学报》 2000年第1期119-121,共3页 Journal of the Fourth Military Medical University
关键词 强的松龙 葡聚糖 连接物 结肠定位药物 colon specific drug dextran hydrolysis
  • 相关文献

参考文献6

  • 1[1]McLead AD, Friend DR, Tozer TN. Glucocorticiod dextran conjugtes as potential prodrug delivery: Hydrolysis in rat gastrointestinal tract contents [J]. J Pharm Sci, 1994;83(9):1284-1288.
  • 2[2]McLead AD, Friend DR, Tozer TN. Synthesis and chemical stability of glucoc orticoid-dextran esters: Potential prodrugs for colon-specific delivery [J]. Int J Pharm,1993;92(2): 105-114.
  • 3[3]Hanninen O, Lindstrom-Sppa P, Pelkonen K. Role of gut in xenobiotic metabolism [J]. Arch Toxico,1987;60(1): 34-36.
  • 4[4]Williams-Smiths H. Observations on the flora of the alimentary tract of anim als and factors affecting its composition [J]. J Phathol Bacteriol,1965;89 (2): 95-122.
  • 5[5]Davis SS, Hardy JG, Fara JW. Transit of pharmaceutical dosage forms through the small intestine [J]. Gut,1986;27(8): 886-892.
  • 6[6]Hardy JG,Wilson CG, Wood E. Drug delivery to the proximal colon [J ]. J Pharm Pharmacol,1985;37(12): 847-877.

同被引文献55

  • 1李国锋,陈建海,刘立捷,郭丹,晏媛,许重远,陈志良.结肠菌群触发型5-氨基水杨酸壳聚糖胶囊大鼠体内的吸收与分布研究[J].第一军医大学学报,2003,23(5):431-434. 被引量:14
  • 2Ishibashi T, pitcairn G R, Yoshino H. Seintigraphic evaluation of a new capule-type eolon specific drug delivery system in healthy volunteers, J Pharm Sci, 1998;87(5):531.
  • 3Kimura T, Yamaguchi T, Usuki K, et al.Colonic mucosa-specific "pro-antedrugs" for oral treatment of ulcerative colitis: design,synthesis and fate of methyl 20-glucopyranosyloxy prednisolonates. J Controlled Release, 1994;30(2): 125.
  • 4Rodriguea M, Vila-jato J L, Torres D. Design of a new multipartlculate system for potential site-specific and controlled drug delivery to the colon region. J Controlled Release,1998;55(1):67.
  • 5Lee S S, La S B, Lim C B, et al. Colon selective drug delivery. Int. Cl: A61K 009/22,USA. 6319518,2001-11-20.
  • 6Carelli V,Di Colo G,Nannipieri E et al.Polyoxyethylene-poly(methacrylic acid-comethyl methacrylate)compounds for site-specific peroral delivery.International Journal of Pharmaceutics, 2000; 53 (1):7.
  • 7Leopold C S, Eikeler D. Eugragit E as coating material for the pH-controlled drug release in the topical treatment of inflammatory bowel disease (IBD). J Drug Target, 1998;6(2):85.
  • 8Chourasia M K, Jain S K. Pharmaceutical approaches to colon targeted drug delivery syetems. J Pharm Pharm Sci, 2003;6(1):33.
  • 9Krishnaiah Y S, Muzib Y I, Rao G S,, Bhaskar P et al. Studies on the development:Of colon targeted oral drug delivery systems for ornidazole in the treatment of amoebiasis. Drug Delivery, 2003;10(2):111.
  • 10Khan M Z, Stedul H P, Kurjakovic N. A pHdependent colon-targeted oral drug delivery system using methacrylic acid copolymers. Ⅱ. Manipulation of drug release using Eudragit L100 and Eudragit S100 combinations. Drug Dev Ind Pharm ,2000; 26(5) : 549.

引证文献8

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部